Product Liability – $2.2 Billion in Drug-Marketing Settlement

November 4, 2013

Health-care behemoth Johnson & Johnson will pay $2.2 billion to resolve civil and criminal allegations involving the marketing of off-label, unapproved uses for several prescription drugs, Justice Department officials announced Monday.The cases include allegations of kickbacks to doctors and pharmacies to promote usage of the anti-psychotic drugs Risperdal and Invega, and a heart-failure drug, Natrecor.

Read more: Johnson & Johnson agrees to pay $2.2 billion in drug-marketing settlement – The Washington Post.

Share This:
  • Digg
  • Facebook
  • Twitter
  • Technorati
  • LinkedIn

chicago evanston top 100 personal injury attorneys
chicago evanston million dollar advocate personal injury attorneys
chicago evanston personal injury law guru attorneys

evanston chicago personal injury attorneys testimonials

“I just wanted to say hello and a BIG thanks to you for what you did for me. It was a year ago, that I got the settlement, and I’m still stunned at what transpired… and so quickly.”J.A.